Advertisement

Neurosurgical Review

, Volume 9, Issue 1–2, pp 13–22 | Cite as

The future role of neurosurgery in the care of cerebral tumors

  • Keiji Sano
Cerebral tumors

Summary

Diagnostic methods to discover a brain tumor and surgical techniques to remove it are steadily advancing. Most well-demarcated tumors can be removed by operation alone. Malignant, invasive tumors, however, will continue to offer a difficult and serious problem except when they are found while still very small in size, by elaborate diagnostic tools and except when they are conveniently located. For those tumors, surgery alone is not enough. Extermination of tumor cells by surgery, radiotherapy, chemotherapy, immunotherapy, etc., or combinations of these has achieved some results but with considerable limitations. We must search for the ways of peaceful coexistence with tumor cells, i.e., living with the tumor cells which are kept non-dividing and nonmetastasizing by some means. Recent developments in oncology, such as discovery of c-onc genes, various growth factors, etc., give us some hope in the researches in this direction.

Keywords

Brain tumor growth factors labelling index oncogenes 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Bishop, J. M.: Oncogenes. Sci. Am. 246, No. 3 (1982) 68–78Google Scholar
  2. [2]
    Buick, R. N., M. N. Pollak: Perspectives on clonogenic tumor cells, stem cells, and oncogenes. Cancer Res. 44 (1984) 4909–4918PubMedGoogle Scholar
  3. [3]
    Committee of Brain Tumor Registry in Japan: Brain tumor registry in Japan Vol. 5, National Cancer Center, Tokyo 1984Google Scholar
  4. [4]
    Cutler, S. J.: Computation of survival rate. NCI Monograph 15 (1964) 381–385Google Scholar
  5. [5]
    Gratzner, H. G.: Monoclonal antibody to 5-bromoand 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 218 (1982) 474–476PubMedGoogle Scholar
  6. [6]
    Hoshino, T.: A commentary on the biology and growth kinetics of low-grade and high-grade gliomas. J. Neurosurg. 61 (1984) 895–900PubMedGoogle Scholar
  7. [7]
    Hoshino, T., K. Nomura, C. B. Wilson, et al.: The distribution of nuclear DNA from human brain-tumor cells. Flow cytometric studies. J. Neurosurg. 49 (1978) 13–21PubMedGoogle Scholar
  8. [8]
    Hoshino, T., J. J. Townsend, I. Muraoka, et al.: An autoradiographic study of human gliomas: growth kinetics of anaplastic astrocytoma and glioblastoma multiforme. Brain 103 (1980) 967–984PubMedGoogle Scholar
  9. [9]
    Hoshino, T., C. B. Wilson: Cell kinetic analyses of human malignant brain tumors (gliomas). Cancer 44 (1979) 956–962PubMedGoogle Scholar
  10. [10]
    Hoshino, T., C. B. Wilson, M. L. Rosenblum, et al.: Chemotherapeutic implications of growth fraction and cell cycle time in glioblastoma. J. Neurosurg. 43 (1975) 127–135PubMedGoogle Scholar
  11. [11]
    Land, H., L. F. Parada, R. A. Weinberg: Cellular oncogenes and multistep carcinogenesis. Science 222 (1983) 771–778PubMedGoogle Scholar
  12. [12]
    Nagashima, T., S. J. DeArmond, J. Murovic, et al.: Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumors. Acta Neuropathol. (in press)Google Scholar
  13. [13]
    Nagashima, T., T., Hoshino: A review of cell kinetic studies on brain tumors with a special reference to anti-bromodeoxyuridine monoclonal antibody method. Neurol. Surg. 12 (1984) 1007–1018 (Japan)Google Scholar
  14. [14]
    Reitsma, P. H., P. G. Rothberg, S. M. Astrin, et al.: Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite. Nature 306 (1983) 492–494PubMedGoogle Scholar
  15. [15]
    Sano, K.: Chemo-radiotherapy of malignant brain tumors. In: Carrea, R.: Proc. 6th Internat. Congr. Neurol. Surg. pp. 79–87. Excerpta Medica, Amsterdam—Oxford 1977Google Scholar
  16. [16]
    Sano, K.: Integrative treatment of gliomas. Clin. Neurosurg. 30 (1983) 93–124PubMedGoogle Scholar
  17. [17]
    Sano, K., T. Hoshino, M. Nagai: Radiosensitization of brain tumor cells with a thymidine analogue (Bromouridine). J. Neurosurg. 28 (1968) 530–538PubMedGoogle Scholar
  18. [18]
    Sporn, M. B., G. J. Todaro: Autocrine secretion and malignant transformation of cells. N. Engl. J. Med. 303 (1980) 878–880PubMedGoogle Scholar
  19. [19]
    Todaro, C. F., C. Fryling, J. E. DeLarco: Transforming growth factors (TGFs) produced by certain human tumor cells: polypeptides that interact with epidermal growth factor (EGF) receptors. Proc. Natl. Acad. Sci. USA 77 (1980) 5258–5262PubMedGoogle Scholar

Copyright information

© Walter de Gruyter & Co. 1986

Authors and Affiliations

  • Keiji Sano
    • 1
  1. 1.Department of NeurosurgeryTeikyo UniversityTokyoJapan

Personalised recommendations